Ioanna Kyrikou

Losartan's molecular basis of interaction with membranes and AT1 receptor.

Physicochemical methods were used to study the thermal and dynamic changes caused by losartan in the membrane bilayers. In addition, molecular modeling was implemented to explore its topography both in membranes and AT(1) receptor. Its incorporation resulted in the modification of thermal profile of dipalmitoyl phosphatidylcholine (DPPC) bilayers in a concentration dependent way up to 20mol% as it is depicted from the combination of differential scanning calorimetry (DSC) and MAS data. In particular, the presence of losartan caused lowering of the phase transition temperature and abolishment of the pretransition. T(1) experiments revealed the location of the drug into the membrane bilayers. The use of a combination of biophysical methods along with docking experiments brought out a possible two-step mechanism which involves incorporation of losartan at the interface of membrane bilayers and diffusion in the upper parts of AT(1) receptor helices IV-VII.

Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulations.

The conformational properties of AT1 antagonist valsartan have been analyzed both in solution and at the binding site of the receptor. Low energy conformations of valsartan in solution were explored by NMR spectroscopy and molecular modeling studies. The NMR results showed the existence of two distinct and almost isoenergetic conformations for valsartan (cis:trans ratio around the amide bond approximately 40:60) that coalesce at the temperature range of 55-60 degrees C in agreement with previous in solution conformational analysis study (Fang et al. Magn. Reson. Chem. 2007, 45, 929-936). Quantum mechanics and ONIOM calculations revealed that the bulky valsartan substituents actually contribute to stabilization of the transition state for interconversion. In silico docking and Molecular Dynamic studies were applied to study binding of valsartan at the AT1 receptor site models, explicitly solvated and embedded in lipid bilayers and solvent molecules. These studies revealed that the majority of docked poses adopted a trans (major) conformation. Of paramount and maybe biological importance are the MD simulations results which showed that the two acidic groups of valsartan are bridged through LYS199 enabling it for multiple hydrogen bond interactions. In a lipid bilayer environment these interactions are enhanced, designating the important role of lipid bilayers for the better binding of valsartan and its stabilization at the active site.

Conformation and Bioactivity. Design and Discovery of Novel Antihypertensive Drugs

Peptidomimitism is applied to the medicinal chemistry in order to synthesize drugs that devoid of the disadvantages of peptides. AT1 antagonists constitute a new generation of drugs for the treatment of hypertension designed and synthesized to mimic the C-terminal segment of Angiotensin II and to block its binding action on AT1 receptor. An effort was made to understand the molecular basis of hypertension by studying the conformational analysis of Ang II and its derivatives as well as the AT1 antagonists belonging to SARTANs class of molecules. Such studies offer the possibility to reveal the stereoelectronic factors responsible for bioactivity of AT1 antagonists and to design and synthesize new analogs. An example will be given which proves that drugs with better pharmacological and financial profiles may arise based on this rational design.

Efforts to Understand the Molecular Basis of Hypertension Through Drug:Membrane Interactions

Biological membranes play an essential role in the drug action. They constitute the first barrier for drugs to exert their biological action. AT1 antagonists are amphiphilic molecules and are hypothesized to act on AT1 receptor through incorporation (first step) and lateral diffusion through membrane bilayers (second step). Various biophysical methods along with Molecular Modelling were applied in order to explore the plausible two step proposed mechanism of action for this class of antihypertensive drugs.

Structural elucidation and conformational properties of the toxin paralysin β-Ala–Tyr

Larval extracts of the homotetabolous insects (i.e., Neobelleria Bullata-Insecta Diptera), cause paralysis followed by death when injected into adult flesh flies. The reason for causing these lethal effects is because the extracts contain endogenous toxins widely spread over the class of insects. Since their major effect is the paralysis they are called paralysins and are present through all the development stages. Their concentration gradually increases from larvae stage over pupation to late pharate adults indicating that paralysins have an active role in the metamorphosis. The prototype pharmacologically important dipeptide beta-alanine-tyrosine was synthesized and submitted to conformational analysis studies in hydrophilic and amphoteric environments in order to reveal the stereoelectronic properties responsible for its activity.

The use of computational analysis to design novel drugs

Hypertension is a growing undesired symptom which damages health and threatens mostly the developed societies. It is estimated that 20% of the Greek population suffers from hypertension. Research efforts for the controlling of hypertension are focused in blocking Ang II release and more recently in competing Ang II binding on AT1 receptors. This latest approach generated the synthesis of losartan and promoted it in the pharmaceutical market (COZAAR). Other derivative drugs which fall into SARTANs class followed. To comprehend the stereoelectronic requirements which may lead to the better understanding of the molecular basis of hypertension, the stereochemical features of angiotensin II, its peptide antagonists sarmesin and sarilesin, synthetic peptide analogs, AT1 non-peptide antagonists commercially available as well as synthetic ones were explored. AT1 antagonists are designed to mimic the C-terminal part of Ang II [1]. In this aspect, it is proposed that the butyl chain of losartan may mimic the isopropyl chain of Ile, the tetrazole ring mimics the C-terminal carboxylate group and the imidazole ring the corresponding imidazole ring of His [6]. The drug design is based on the optimization of superimposition studies of losartan with C-terminal part of sarmesin [2].